• No results found

Long-term outcome of rectal cancer treatment Lange, M.M.

N/A
N/A
Protected

Academic year: 2021

Share "Long-term outcome of rectal cancer treatment Lange, M.M."

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Long-term outcome of rectal cancer treatment

Lange, M.M.

Citation

Lange, M. M. (2009, February 18). Long-term outcome of rectal cancer treatment. Retrieved from https://hdl.handle.net/1887/13523

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/13523

Note: To cite this publication please use the final published version (if applicable).

(2)

Long-term outcome of rectal cancer treatment

Marilyne Lange

(3)

Cover: Le Juste Milieu (2008) by GJD van Acker & JFM Lange - Studio J.C. Sacque.

© 2009, M.M. Lange ISBN 978-90-8559-480-2

Printed by Optima Grafische Communicatie, Rotterdam

The printing of this thesis was sponsored by Coloplast BV, EuroTec BV, Braun Medical BV, Amgen BV, Welmed BV, Novartis Oncology, Nycomed Nederland BV, Covidien Nederland BV, Olympus Nederland BV.

(4)

Long-term outcome of rectal cancer treatment

Proefschrift

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden,

op gezag van Rector Magnificus prof.mr. P.F. van der Heijden,

volgens besluit van het College voor Promoties

te verdedigen op woensdag 18 februari 2009

klokke 15.00 uur

door

Marilyne Michèle Lange geboren te Uccle (België)

in 1983.

(5)

PROMOTIECOMMISSIE

Promotor: Prof. Dr. C.J.H. van de Velde

Referent: Prof. Dr. Th. Wiggers (Universitair Medisch Centrum Groningen)

Overige leden: Prof. Dr. C.A.M. Marijnen

Dr. H.J. Rutten (Catharina ziekenhuis, Eindhoven) Prof. Dr. R.A.E.M. Tollenaar

(6)

Aan mijn ouders

(7)
(8)

7

CONTENTS

Chapter 1 General introduction and outline 9

Chapter 2 One hundred years of curative surgery for rectal cancer:

1908-2008

Eur J Surg Oncol. In press

19

Chapter 3 Level of arterial ligation in rectal cancer surgery: low tie preferred over high tie. A review.

Dis Colon Rectum. 2008 July; 51(7): 1139–1145.

37

Chapter 4 Risk factors for sexual dysfunction after rectal cancer treat- ment

Eur J Ca. In press

53

Chapter 5 Urinary dysfunction after rectal cancer treatment is mainly caused by surgery

Br J Surg. 2008 Aug;95(8):1020-8.

73

Chapter 6 Risk factors for faecal incontinence after rectal cancer treatment

Br J Surg. 2007 Oct;94(10):1278-84.

91

Chapter 7 Faecal and urinary incontinence after multimodality treat- ment of rectal cancer

PLoS Med. 2008 Oct 7;5(10):e202.

107

Chapter 8 Causes of faecal and urinary incontinence after total me- sorectal excision for rectal cancer based on cadaveric surgery J Clin Oncol. 2008 Sep 20;26(27):4466-72.

119

Chapter 9 Leukocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in gastrointesti- nal cancer patients

Submitted

133

Chapter 10 Discussion and future perspectives 147

(9)

Contents

8

Summary 163

Nederlandse samenvatting 169

Curriculum vitae 175

Nawoord 177

Referenties

GERELATEERDE DOCUMENTEN

Of 445 patients who answered the question concerning bladder emptying at 5 years, 351 patients had normal preoperative function; 90 (25.6 percent) of these developed

This study identified tumour height and excessive blood loss as independent predic- tors of faecal incontinence after LAR with TME in patients who had PRT, whereas no risk factors

Although the exact etiology of incontinence problems after multimodality treat- ment of rectal cancer is unknown, specific technical aspects of the surgical procedure play a

Subsequently, to estimate the risk of simultaneous damage to the LAN in case of damage to the pelvic splanchnic nerves, faecal and urinary incontinence were related to difficulty

Disease-free survival (illustrated by the two upper curves) and recurrence (illustrated by the two lower curves) of 341 patients who were allocated to leukocyte depleted or

16 Therefore, patients with early rectal cancer after neoadjuvant treatment (ypT1 and ypT2) might be considered candidates for local excision by means of transanal endoscopic

Urinary dysfunction (UD) after rectal cancer treatment is a common problem, of which the contributing factors are unclear. To evaluate UD during five years after TME and to

Vijf jaar na TME gaf 38.1 procent van de patiënten aan incontinent te zijn voor urine, waarvan 72.0 procent preoperatief geen incontinentieklachten had.. Preoperatieve